Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
Tactile Medical entered an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device, specifically targeting VA and DoD patients. The transaction includes a $3 million upfront payment and minimum purchase obligations, adding a new treatment option for earlier-stage chronic swelling to Tactile’s portfolio.
Key figures
- Deal Value Usd
- 3000000
- Upfront payment
- $3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.